Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Pons

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|March 6, 2016
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker DesignMagdalena Dorywalska, Russell Dushin, Ludivine Moine, et al.
Plos One|August 26, 2020
Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective studyAlberto Alonso-Fernández, Nuria Toledo-Pons, Borja G Cosío, et al.
The Journal of Biological Chemistry|February 2, 2012
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9Javier Chaparro-Riggers, Hong Liang, Rachel M DeVay, et al.
Journal of Molecular Biology|October 7, 2014
Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencingThomas Van Blarcom, Andrea Rossi, Davide Foletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degenerationJin-Dong Ding, Lincoln V Johnson, Rolf Herrmann, et al.
International Journal of Molecular Sciences|July 13, 2024
Cardiopulmonary Complications after Pulmonary Embolism in COVID-19Carla Suarez-Castillejo, Néstor Calvo, Luminita Preda, et al.
Mabs|December 12, 2017
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodiesThomas Van Blarcom, Kevin Lindquist, Zea Melton, et al.
Bioconjugate Chemistry|February 3, 2015
Effect of attachment site on stability of cleavable antibody drug conjugatesMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Plos One|July 11, 2015
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC EfficacyMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|March 6, 2016
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker DesignMagdalena Dorywalska, Russell Dushin, Ludivine Moine, et al.
Plos One|August 26, 2020
Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective studyAlberto Alonso-Fernández, Nuria Toledo-Pons, Borja G Cosío, et al.
The Journal of Biological Chemistry|February 2, 2012
Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9Javier Chaparro-Riggers, Hong Liang, Rachel M DeVay, et al.
Journal of Molecular Biology|October 7, 2014
Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencingThomas Van Blarcom, Andrea Rossi, Davide Foletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degenerationJin-Dong Ding, Lincoln V Johnson, Rolf Herrmann, et al.
International Journal of Molecular Sciences|July 13, 2024
Cardiopulmonary Complications after Pulmonary Embolism in COVID-19Carla Suarez-Castillejo, Néstor Calvo, Luminita Preda, et al.
Mabs|December 12, 2017
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodiesThomas Van Blarcom, Kevin Lindquist, Zea Melton, et al.
Bioconjugate Chemistry|February 3, 2015
Effect of attachment site on stability of cleavable antibody drug conjugatesMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Plos One|July 11, 2015
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC EfficacyMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Pageof 9